Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP7 | Q9UHL4 | 3/20 | 0.60 |
| ▸ | DPP4 | P27487 | 2/20 | 0.60 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.53 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.53 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.48 |
| ▸ | FAP | Q12884 | 1/20 | 0.48 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.48 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.48 |
| ▸ | MMP12 | P39900 | 1/20 | 0.48 |
| ▸ | MMP13 | P45452 | 1/20 | 0.48 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.47 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.46 |
| ▸ | MME | P08473 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | MAOB | P27338 | 1/20 | 0.45 |
| ▸ | ANPEP | P15144 | 1/20 | 0.44 |
| ▸ | ENPEP | Q07075 | 1/20 | 0.44 |
| ▸ | GLA | P06280 | 1/20 | 0.44 |
| ▸ | MEP1A | Q16819 | 1/20 | 0.44 |
| ▸ | MEP1B | Q16820 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2035561 | 1.00 | DPP7 (0.60) | DPP7DPP4FOLH1PIN1FFAR1 | |
| SCHEMBL2030772 | 1.00 | DPP7 (0.60) | DPP7DPP4FOLH1PIN1FFAR1 | |
| SCHEMBL29478390 | 1.00 | DPP7 (0.60) | DPP7DPP4FOLH1PIN1FFAR1 | |
| SCHEMBL2030774 | 1.00 | DPP7 (0.60) | DPP7DPP4FOLH1PIN1FFAR1 | |
| SCHEMBL29557415 | 0.82 | FOLH1 (0.59) | DPP7DPP4FOLH1FAPDPP8 | |
| SCHEMBL29397955 | 0.82 | FOLH1 (0.59) | DPP7DPP4FOLH1FAPDPP8 | |
| SCHEMBL43811 | 0.82 | FOLH1 (0.59) | DPP7DPP4FOLH1FAPDPP8 | |
| SCHEMBL838038 | 0.82 | FOLH1 (0.59) | DPP7DPP4FOLH1FAPDPP8 | |
| SCHEMBL43812 | 0.82 | FOLH1 (0.59) | DPP7DPP4FOLH1FAPDPP8 | |
| SCHEMBL14860190 | 0.81 | DPP7 (0.52) | DPP7DPP4FOLH1PIN1FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120202010-A | Ligand-oligonucleotide conjugates and linkers for use therewith | 上海京新生物医药有限公司 | 2025-06-24 | — | — | CN | disclosed |
| CN-118879592-A | Unnatural base pair compositions and methods of use | 斯克利普斯研究所 | 2024-11-01 | — | — | CN | disclosed |
| CN-112105627-B | Unnatural base pair compositions and methods of use | 斯克利普斯研究所 | 2024-07-02 | — | — | CN | disclosed |
| CN-118139868-A | Orally bioavailable nucleoside analogs | 维纳拓尔斯制药公司 | 2024-06-04 | — | — | CN | disclosed |
| CN-111182880-B | WNT compositions and process from serum-free culture conditions | 安卡萨再生疗法公司 | 2024-01-09 | — | — | CN | disclosed |
| CN-116457034-A | Nanomaterial and method of use thereof | 康涅狄格大学 | 2023-07-18 | — | — | CN | disclosed |
| CN-116445398-A | WNT composition and purification method | 小利兰斯坦福大学托管委员会 | 2023-07-18 | — | — | CN | disclosed |
| EP-4041249-A1 | COMPOSITIONS AND METHODS FOR IN VIVO SYNTHESIS OF UNNATURAL POLYPEPTIDES | The Scripps Research Institute (US) | 2022-08-17 | — | — | EP | disclosed |
| WO-2022170108-A1 | PEPTIDOMIMETIC MACROCYCLES AND USES THEREOF IN PREVENTION OF RADIATION INJURY | AILERON THERAPEUTICS, INC. (US) | 2022-08-11 | — | — | WO | disclosed |
| CN-114853866-A | Peptidomimetic macrocycles | 艾瑞朗医疗公司 | 2022-08-05 | — | — | CN | disclosed |
| CN-114761026-A | Compositions and methods for in vivo synthesis of non-native polypeptides | 斯克利普斯研究所 | 2022-07-15 | — | — | CN | disclosed |
| CN-114746099-A | Eukaryotic semisynthetic organisms | 斯克利普斯研究所 | 2022-07-12 | — | — | CN | disclosed |
| CN-112500466-B | Peptidomimetic macrocycles | 艾瑞朗医疗公司 | 2022-05-03 | — | — | CN | disclosed |
| EP-3983543-A1 | REAGENTS AND METHODS FOR REPLICATION, TRANSCRIPTION, AND TRANSLATION IN SEMI-SYNTHETIC ORGANISMS | The Scripps Research Institute (US) | 2022-04-20 | — | — | EP | disclosed |
| EP-3976635-A1 | METHODS OF TREATING HYPERLIPIDEMIA CONDITIONS WITH NETRIN-1 COMPOUNDS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-04-06 | — | — | EP | disclosed |
| CN-108348571-B | Peptidomimetic macrocycles and uses thereof | 艾瑞朗医疗公司 | 2022-03-22 | — | — | CN | disclosed |
| CN-114206911-A | Methods of treating hyperlipidemia disorders with axon-targeting factor-1 compounds | 加利福尼亚大学董事会 | 2022-03-18 | — | — | CN | disclosed |
| CN-114207129-A | Agents and methods for replication, transcription and translation in semi-synthetic organisms | 斯克利普斯研究所 | 2022-03-18 | — | — | CN | disclosed |
| CN-114173878-A | Peptidomimetic macrocycles and uses thereof | 艾瑞朗医疗公司 | 2022-03-11 | — | — | CN | disclosed |